Michael G. Grey, Director at Mirati Therapeutics, Inc. (MRTX), sold 4,724 shares at $91.20 ($435K) on 2019-08-12, disclosed to the SEC on 2019-08-14.
Open-market sale of $435k MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.20 | 1,032 | $94K | 21.6% |
| 2 | $91.20 | 1,032 | $94K | 21.6% |
| 3 | $92.34 | 1,100 | $102K | 23.3% |
| 4 | $93.18 | 650 | $61K | 13.9% |
| 5 | $93.18 | 650 | $61K | 13.9% |
| 6 | $93.98 | 260 |
| $24K |
| 5.6% |
| Total | $92.16 avg | 4,724 | $435K | 100% |
| Filing → |
| MIRM | SELL | 2025-11-25 | $3.5M | — | Filing → |
| MIRM | SELL | 2023-09-14 | $467K | — | Filing → |
| MIRM | SELL | 2023-06-09 | $424K | — | Filing → |